ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

TYRA Tyra Biosciences Inc

18.58
0.08 (0.43%)
取引時間後
最終更新日: 05:00:10
15分遅延
名称 銘柄コード 市場 種別
Tyra Biosciences Inc TYRA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.08 0.43% 18.58 05:00:10
始値 安値 高値 終値 前日終値
18.80 16.88 19.39 18.58 18.50
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/1005:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1005:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/5/1005:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1005:08EDGAR2Form 8-K - Current report
2024/5/1005:05PRNUSTyra Biosciences Reports First Quarter 2024 Financial..
2024/5/0805:34EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/5/0805:29EDGAR2Form 8-K - Current report
2024/5/0805:05PRNUSTyra Biosciences Announces Appointments of Susan Moran,..
2024/3/2005:05PRNUSTyra Biosciences Reports Fourth Quarter and Full Year 2023..
2024/3/0907:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0607:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0108:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2806:05PRNUSTyra Biosciences to Present at Upcoming Investor Conferences
2024/2/1511:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1406:36EDGAR2Form D - Notice of Exempt Offering of Securities
2024/2/1306:46EDGAR2Form 144 - Report of proposed sale of securities
2024/2/1009:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0806:05PRNUSTyra Biosciences to Present at Oppenheimer's 34th Annual..
2024/2/0710:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0706:56EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0520:05EDGAR2Form 8-K - Current report
2024/2/0307:04EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0222:00PRNUSTyra Biosciences, Inc. Announces $200 Million Private..
2024/2/0207:30PRNUSTyra Biosciences Receives FDA Rare Pediatric Disease..
2024/2/0207:24EDGAR2Form 8-K - Current report
2023/12/2223:00EDGAR2Form 8-K - Current report
2023/12/2223:00PRNUSTyra Biosciences Doses First Patient with TYRA-200 and..
2023/11/0906:05PRNUSTyra Biosciences to Participate in 2023 Jefferies London..
2023/11/0806:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0806:07EDGAR2Form 8-K - Current report
2023/11/0806:05PRNUSTyra Biosciences Reports Third Quarter 2023 Financial..
2023/10/2705:50EDGAR2Form 8-K - Current report
2023/9/2121:00PRNUSTyra Biosciences Announces Oral Presentations on TYRA-300..
2023/9/2008:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1305:05PRNUSTyra Biosciences to Participate at 2023 Cantor Global..
2023/8/1105:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1105:21EDGAR2Form 8-K - Current report
2023/8/1105:05PRNUSTyra Biosciences Reports Second Quarter 2023 Financial..
2023/8/0206:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0206:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0121:54DJNTyra Biosciences Gets FDA Orphan Designation for TYRA-300 in..
2023/8/0121:00PRNUSTyra Biosciences Announces FDA Orphan Drug Designation for..
2023/7/2209:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1808:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1307:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0406:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/2909:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/5/2521:00PRNUSTyra Biosciences to Participate in Upcoming Investor..

最近閲覧した銘柄

Delayed Upgrade Clock